Abstract
Mitochondrial carnitine palmitoyltransferase II (CPT II) deficiency is the most common inherited disorder of lipid metabolism in adults. Currently the routine diagnosis is based on the determination of CPT enzyme activity in muscle tissue. We have analysed the tandem mass spectra of serum acylcarnitines of nine CPT II-deficient patients. These spectra were compared to those of a cohort of 99 patients with other neuromuscular disorders and metabolic conditions supposed to cause alterations of the long-chain acylcarnitines. The spectra in CPT II deficiency showed characteristic elevations of C16:0 and C18:1 acylcarnitines while acetylcarnitine C2 was not elevated. In the present study, the ratio (C16:0+C18:1)/C2 has detected all CPT II deficiencies and discriminated them from unspecific alterations of serum acylcarnitines. The ratios of CPT II-deficient patients showed virtually no overlap with those observed in patients with other neuromuscular disorders. We suggest mass spectrometry of serum acylcarnitines as a rapid screening test that should be included early in the diagnostic work-up of patients with recurrent myoglobinuria, recurrent muscular weakness and myalgia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Al Aqeel AI, Rashed MS, Wanders RJ (1999) Carnitine-acylcarnitine translocase deficiency is a treatable disease. J Inherit Metab Dis 22: 271–275.
Albers S, Marsden D, Quackenbush E, Stark AR, Levy HL, Irons M (2001) Detection of neonatal carnitine palmitoyltransferase II deficiency by expanded newborn screening with tandem mass spectrometry. Pediatrics 107: E103.
Angelini C, Freddo L, Battistella P, et al (1981) Carnitine palmityl transferase deficiency: clinical variability, carrier detection, and autosomal-recessive inheritance. Neurology 31: 883–886.
Bonnefont JP, Demaugre F, Prip-Buus C, et al (1999) Carnitine palmitoyltransferase deficiencies. Mol Genet Metab 68: 424–440.
Brivet M, Boutron A, Slama A, et al (1999) Defects in activation and transport of fatty acids. J Inherit Metab Dis 22: 428–441.
Bruno C, Bado M, Minetti C, Cordone G, DiMauro S (2000) Novel mutation in the CPT II gene in a child with periodic febrile myalgia and myoglobinuria. J Child Neurol 15: 390–393.
Deufel T, Wieland OH (1983) Sensitive assay of carnitine palmitoyl transferase activity in tissue homogenates with a modified spectrophotometric method for enzymatic carnitine determination. Clin Chim Acta 135: 247–251.
DiMauro S, DiMauro PM (1973) Muscle carnitine palmityltransferase deficiency and myoglobinuria. Science 182: 929–931.
Eaton S, Bartlett K, Pourfarzam M (1996) Mammalian mitochondrial beta-oxidation. Biochem J 320: 345–357.
Engel WK, Vick NA, Glueck CJ, Levy RI (1970) A skeletal-muscle disorder associated with intermittent symptoms and a possible defect of lipid metabolism. N Eng J Med 282: 697–704.
Gempel K, Kottlors M, Jaksch M, Gerbitz KD, Bauer MF (1999) Adult carnitine palmitoyltransferase II deficiency: detection of characteristic carnitine esters in serum by tandem mass spectrometry. J Inherit Metab Dis 22: 941–942.
Gempel K, Praun CV, Baumkoetter J, et al (2001) “Adult” form of muscular carnitine palmitoyltransferase II deficiency: manifestation in a 2-year-old child. Eur J Pediatr 160: 548–551.
Hertel K, Gellerich FN, Hein W, Zierz S (1999) Kinetic investigation of carnitine palmitoyltransferases in homogenates of human skeletal muscle using L-amino-carnitine and malonyl-CoA. Adv Exp Med Biol 466: 87–93.
Hug G, Bove KE, Soukup S (1991) Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II. N Engl J Med 325: 1862–1864.
Hurvitz H, Klar A, Korn-Lubetzki I, Wanders RJ, Elpeleg ON (2000) Muscular carnitine palmitoyltransferase II deficiency in infancy. Pediatr Neurol 22: 148–150.
Martin MA, Rubio JC, De Bustos F, et al (1999) Molecular analysis in Spanish patients with muscle carnitine palmitoyltransferase deficiency. Muscle Nerve 22: 941–943.
Roe CR, Ding J (2001) Mitochondrial fatty acid oxidation disorders. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 8 edn. New York: McGraw-Hill, 2297–2326.
Roschinger W, Muntau AC, Duran M, et al (2000) Carnitine-acylcarnitine translocase deficiency: metabolic consequences of an impaired mitochondrial carnitine cycle. Clin Chim Acta 298: 55–68.
Schaefer J, Jackson S, Taroni F, Swift P, Turnbull DM (1997) Characterisation of carnitine palmitoyltransferases in patients with a carnitine palmitoyltransferase deficiency: implications for diagnosis and therapy. J Neurol Neurosurg Psychiatry 62: 169–176.
Smail D, Gambino L, Boles C, Vladutiu GD (1999) Rapid, cost-effective gene mutation screening for carnitine palmitoyltransferase II deficiency using whole blood on filter paper. Clin Chem 45: 2035–2038.
Taroni F, Verderio E, Dworzak F, Willems PJ, Cavadini P, DiDonato S (1993) Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients. Nature Genetics 4: 314–320.
Vreken P, van Lint AE, Bootsma AH, Overmars H, Wanders RJ, van Gennip AH (1999) Rapid diagnosis of organic acidemias and fatty-acid oxidation defects by quantitative electrospray tandem-MS acylcarnitine analysis in plasma. Adv Exp Med Biol 466: 327–337.
Wanders RJ, Vreken P, den Boer ME, Wijburg FA, van Gennip AH, IJlst L (1999) Disorders of mitochondrial fatty acyl-CoA β-oxidation. J Inherit Metab Dis 22: 442–487.
Yang BZ, Mallory JM, Roe DS, et al (2001) Carnitine/acylcarnitine translocase deficiency (neonatal phenotype): successful prenatal and postmortem diagnosis associated with a novel mutation in a single family. Mol Genet Metab 73: 64–70.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gempel, K., Kiechl, S., Hofmann, S. et al. Screening for Carnitine Palmitoyltransferase II Deficiency by Tandem Mass Spectrometry. J Inherit Metab Dis 25, 17–27 (2002). https://doi.org/10.1023/A:1015109127986
Issue Date:
DOI: https://doi.org/10.1023/A:1015109127986